THOMAS, MCNERNEY & PARTNERS EXPANDS TEAM AND MOVES WEST COAST OFFICE TO SAN DIEGO

Lawrence C. Fritz, Ph.D., Experienced Biotechnology Entrepreneur, Joins Leading Health Care Venture Firm as Entrepreneur In Residence

San Diego, CA - February 23, 2011

Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, will be relocating its West Coast office from San Francisco to San Diego. Thomas, McNerney partner Pratik Shah, Ph.D. announced the move at BIOCOM’s first global partnering conference being held in San Diego.

“Southern California is home to many top-tier scientific and medical centers; it’s long been a fertile breeding ground for successful medical technology companies, and it’s populated by some of the smartest, most capable people in the country,” Dr. Shah said. “It has all the ingredients that make it an ideal home for Thomas, McNerney’s West Coast office.” Thomas, McNerney & Partners has ten investments on the West Coast, six of which are in Southern California.

In addition, well known San Diego biopharmaceutical executive Larry Fritz, Ph.D. has joined Thomas, McNerney as an Entrepreneur in Residence and will be based out of the firm’s new West Coast office. Dr. Fritz has founded or co-founded a string of successful biotechnology companies including Athena Neurosciences, Idun, Conforma, Cabrellis and Covella. He will assist Thomas, McNerney in selecting investments and building companies.

“Larry has had a long and distinguished career in founding and managing biotechnology companies,” said Dr. Shah. “Importantly, he has been especially successful in creating value for investors and engineering profitable exits in multiple private companies. Strategically, operationally and scientifically, he is a good fit for the way we do business at Thomas, McNerney, and he will be a great addition to our team.”

About Thomas, McNerney & Partners
Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management, focused on investing in life science and medical technology companies at all stages of development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies, as well as recapitalizations. The firm has offices in Connecticut, Minnesota and California. For further information, please visit www.tm-partners.com.

Contact:
Margaret M. Silverman
Head of Investor Relations
msilverman@tm-partners.com
203-978-2007